Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Cardiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Transcoronary transplantation of progenitor cells after myocardial infarction.N Engl J Med. 2006; 355: 1222-1232
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).Circulation. 2002; 106: 3009-3017
- Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.Circulation. 2005; 112: I178-I183
- Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up.Eur Heart J. 2009; 30: 1986-1994
- Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.Circulation. 2005; 112: 1748-1755
- Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.Am Heart J. 2009; 157: 541-547
- Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.Eur Heart J. 2008; 29: 2723-2732
- Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.Lancet. 2006; 367: 113-121
- Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.Circulation. 2006; 114: I145-I151
- Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.N Engl J Med. 2006; 355: 1199-1209
- Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.Int J Cardiol. 2008; 128: 185-192
- Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.Circulation. 2006; 113: 1287-1294
- Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.J Am Coll Cardiol. 2003; 41: 879-888
- Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study.J Am Coll Cardiol. 2007; 49: 2373-2374
- Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.N Engl J Med. 2006; 355: 1210-1221
- Autologous bone-marrow stem-cell transplantation for myocardial regeneration.Lancet. 2003; 361: 45-46
- Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.J Am Coll Cardiol. 2005; 46: 1651-1658
- Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.Circulation. 2002; 106: 1913-1918
- Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction.Circ J. 2007; 71: 1199-1207
- Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.Eur Heart J. 2009; 30: 1313-1321
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.Lancet. 2004; 364: 141-148
- The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.J Am Coll Cardiol. 2009; 53: 2262-2269
- Adult cardiac stem cells are multipotent and support myocardial regeneration.Cell. 2003; 114: 763-776
- Stem cells. Breaking the brain-blood barrier.Nature. 1999; 397: 569-570
- Transplanted bone marrow regenerates liver by cell fusion.Nature. 2003; 422: 901-904
- Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.Nature. 2003; 425: 968-973
- Haematopoietic stem cells do not trans-differentiate into cardiac myocytes in myocardial infarcts.Nature. 2004; 428: 664-668
- Little evidence for developmental plasticity of adult hematopoietic stem cells.Science. 2002; 297: 2256-2259
- The inflammatory response in myocardial infarction.Cardiovasc Res. 2002; 53: 31-47
- Oxidative stress and left ventricular remodelling after myocardial infarction.Cardiovasc Res. 2009; 81: 457-464
- The pathology of myocardial infarction in the pre- and post-interventional era.Heart. 2006; 92: 1552-1556
- Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes.J Biol Chem. 1998; 273: 18092-18098
- Remodelling of gap junctions and connexion expression in diseased myocardium.Cardiovasc Res. 2008; 80: 9-19
- IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.J Immunol. 2000; 165: 2798-2808
- Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions.Circulation. 1999; 99: 546-551
- Differential effect of anti-TNF-alpha antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion.Shock. 1999; 11: 391-395
- Extracellular matrix remodeling following myocardial injury.Ann Med. 2003; 35: 316-326
- Matricellular proteins in the heart: possible role during stress and remodeling.Cardiovasc Res. 2004; 64: 24-31
- Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.Am J Pathol. 2004; 164: 665-677
- Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.Circulation. 1998; 98: 699-710
- Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.Circulation. 2005; 111: 2935-2942
- Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction.J Exp Med. 2009; 206: 113-123
- Periostin is essential for cardiac healing after acute myocardial infarction.J Exp Med. 2008; 205: 295-303
- Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb).Cardiovasc Res. 2000; 48: 89-100
- Extracellular matrix remodeling in canine and mouse myocardial infarcts.Cell Tissue Res. 2006; 324: 475-488
- The immune system and cardiac repair.Pharm Res. 2008; 58: 88-111
- Healing of myocardial infarcts in dogs. Effects of late reperfusion.Circulation. 1995; 92: 1891-1901
- Pretreatment with buflomedil enhances ventricular function by reducing the dysfunctional area after transient coronary artery occlusion.Cardiovasc Res. 1992; 26: 470-475
- Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.Circ Res. 2001; 88: 1080-1087
- Prevention of myocardial damage during coronary intervention.Cardiovasc Hematol Disord Drug Targets. 2006; 6: 77-83
- Muscle injuries and repair: the role of prostaglandins and inflammation.Histol Histopathol. 2003; 18: 1243-1256
- Bone marrow cells regenerate infarcted myocardium.Nature. 2001; 410: 701-705
- Haematopoietic stem cells adopt mature hematopoietic fates in ischaemic myocardium.Nature. 2004; 428: 668-673
- Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy.J Am Coll Cardiol. 2009; 53: 305-308
- Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.J Am Coll Cardiol. 2007; 50: 1761-1767
- Stem cells improve left ventricular function in acute myocardial infarction.Clin Cardiol. 2009; 32: 176-180
- Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction.Circulation. 2001; 103: 1920-1927
- Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.Circulation. 2008; 117: 1555-1562
- A Cre-loxP based system for studying horizontal gene transfer.FEBS Lett. 2007; 581: 2943-2946
- Horizontal transfer of oncogenes by uptake of apoptotic bodies.Proc Natl Acad Sci U S A. 2001; 98: 6407-6411
- Opportunities and challenges for mesenchymal stem cell-mediated heart repair.Curr Opin Lipidol. 2007; 18: 645-649
- Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.Eur Heart J. 2007; 28: 766-772
- Ischemic preconditioning slows energy metabolism and delays ultra structural damage during a sustained ischemic episode.Circ Res. 1990; 66: 913-931
- Clinical effects of ischemic preconditioning.Curr Opin Cardiol. 1999; 14: 340-348
- The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies.Neurology. 2008; 71: 677-684
- Expectation and the placebo effect in Parkinson 's disease patients with subthalamic nucleus deep brain stimulation.Mov Disord. 2006; 21: 1457-1461
- Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.J Interv Cardiol. 2003; 16: 97-105
- Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease.Trends Cardiovasc Med. 2003; 13: 116-122
- The placebo effect in heart failure.Am Heart J. 1990; 120: 1579-1582
- Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.Circulation. 2002; 105: 788-793
- Plasticity of adult stem cells.Cell. 2004; 116: 639-648
- Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages.Nature. 2009; 460: 113-117
- Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart.Dev Cell. 2003; 5: 877-889
- Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification.Cell. 2006; 127: 1151-1165
- Transplantation of fetal mesencephalic tissue in Parkinson's disease.N Engl J Med. 1995; 333: 730-731
- Transplantation of embryonic dopamine neurons for severe Parkinson's disease.N Engl J Med. 2001; 345 ([author reply 147]): 146
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
